BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.

A series of dipyridodiazepinones have been shown to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. The lead compound, BI-RG-587, had a 50% inhibitory concentration of 84 nM against HIV-1 reverse transcriptase activity. This compound reduced plaque formatio...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Richman, D, Rosenthal, A S, Skoog, M, Eckner, R J, Chou, T C, Sabo, J P, Merluzzi, V J
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1991
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC244996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1708976/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.305
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!